These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 7745515
21. Reduced mortality in small premature infants treated at birth with a single dose of synthetic surfactant. Corbet AJ, Long WA, Murphy DJ, Garcia-Prats JA, Lombardy LR, Wold DE. J Paediatr Child Health; 1991 Aug; 27(4):245-9. PubMed ID: 1958425 [Abstract] [Full Text] [Related]
22. Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. van Houten J, Long W, Mullett M, Finer N, Derleth D, McMurray B, Peliowski A, Walker D, Wold D, Sankaran K. J Pediatr; 1992 Feb; 120(2 Pt 2):S40-4. PubMed ID: 1735851 [Abstract] [Full Text] [Related]
23. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1. Corbet A, Bucciarelli R, Goldman S, Mammel M, Wold D, Long W. J Pediatr; 1991 Feb; 118(2):277-84. PubMed ID: 1993961 [Abstract] [Full Text] [Related]
24. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country. da Costa DE, Pai MG, Al Khusaiby SM. Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709 [Abstract] [Full Text] [Related]
25. Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant. Vaucher YE, Harker L, Merritt TA, Hallman M, Gist K, Bejar R, Heldt GP, Edwards D, Pohjavuori M. J Pediatr; 1993 Jan; 122(1):126-32. PubMed ID: 8419599 [Abstract] [Full Text] [Related]
26. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group. Online J Curr Clin Trials; 1992 Nov 10; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614 [Abstract] [Full Text] [Related]
31. Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant. Abbasi S, Bhutani VK, Gerdes JS. J Pediatr; 1993 Mar 10; 122(3):446-52. PubMed ID: 8441104 [Abstract] [Full Text] [Related]
32. Early versus delayed neonatal administration of a synthetic surfactant--the judgment of OSIRIS. The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency--the role of surfactant. Lancet; 1992 Dec 05; 340(8832):1363-9. PubMed ID: 1360087 [Abstract] [Full Text] [Related]
36. Exosurf treatment investigational new drug phase: effect of an individualized third dose in infants with respiratory distress syndrome. Easa D, Pelke S, Nakamura KT, Barrett J, Balaraman V, Loo SW, Ibarra-Pratt E, Smith MB. Pediatr Pulmonol; 1992 Sep 05; 14(1):16-22. PubMed ID: 1437338 [Abstract] [Full Text] [Related]
40. Comparison of the changes in the a/A oxygen ratio after administration of two surfactants for the treatment of neonatal respiratory distress syndrome. Bassiouny MR, Remo C, Cherian E. J Trop Pediatr; 1997 Feb 05; 43(1):38-41. PubMed ID: 9078827 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]